Workflow
Doma (DOMA)
icon
Search documents
DOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization as a Meaningful Step to Enhance Value for Shareholders
Prnewswire· 2025-04-21 12:15
DOMA Perpetual Believes Pacira's Stock Is Undervalued, Presenting an Opportunity to Execute the Largest Buyback in the Company's HistoryMIAMI, April 21, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC (collectively with its affiliates, "DOMA Perpetual" or "We") is a fundamentals-based, value-oriented asset management firm which beneficially owns approximately 4.2% of the outstanding shares of common stock of Pacira BioSciences, Inc. (NASDAQ: PCRX) ("Pacira" or the "Company").Following constructiv ...
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences
Prnewswire· 2025-03-14 12:25
Core Viewpoint - Pacira BioSciences has experienced a significant decline in stock price, down 76% over the last decade, while the S&P 500 has increased by 167% during the same period [2]. The management and board have compensated themselves nearly half a billion dollars, which is approximately 50% of the current market capitalization [2][3]. Management and Board Performance - Under the leadership of CEO Frank Lee, Pacira's stock price has decreased by 33% [1]. There are concerns regarding his push for higher compensation packages for management, which is seen as misaligned with shareholder interests [1][2]. Shareholder Interests - DOMA Perpetual Capital Management, which owns about 4.2% of Pacira's outstanding shares, argues that the current board's capital allocation strategy is detrimental to shareholder value [1][3]. DOMA emphasizes the need for a change in the board's composition to better align with shareholder interests and to rectify a decade of poor stock performance [1][2]. Director Nominees - DOMA has nominated three candidates for the board: Joseph Kromholz, Philip Pucciarelli, and Eric de Armas, who possess extensive experience in strategic capital allocation, risk management, and healthcare banking [1][6]. The nominees are expected to enhance the board's financial sophistication and legal expertise [1][2]. Capital Allocation Strategy - DOMA advocates for accelerating buybacks to return cash to shareholders and believes that the board should avoid substantial risks in capital allocation until there is certainty regarding ongoing intellectual property disputes [3]. The focus should be on prioritizing shareholder interests [3].
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback
Prnewswire· 2025-01-15 13:05
Believes the Board Must Immediately Execute a Tender Offer for 30% of the CompanyLays Out Action Plan to Restore Investor Confidence, Including an additional 10% Share Buyback in 2025Announces Intent to Fight for Shareholders Should InMode Not Take Appropriate ActionMIAMI, Jan. 15, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a significant stockholder of InMode Ltd. (NYSE: INMD) ("InMode") today sent a letter to the Board of Directors of InMode (the "Board") urging the Board to accelerate and ...
DOMA Perpetual Capital Management Announces Intent to Nominate Four Highly Qualified, Independent Director Candidates at 2025 Annual Meeting of Pacira BioSciences, Inc.
Prnewswire· 2024-12-11 13:05
Expresses Conviction in Pacira's IP and Belief that Shares are Significantly UndervaluedUrges Pacira to Immediately Commence Stock Tender Offer with Cash on HandMIAMI, Dec. 11, 2024 /PRNewswire/ -- DOMA Perpetual Capital Management LLC (together with its affiliates, "DOMA"), which beneficially owns approximately 4.14% of the outstanding shares of Common Stock of Pacira BioSciences, Inc. (NASDAQ: PCRX) ("Pacira" or the "Company"), today announced that it intends to nominate four highly-qualified, independent ...
DOMA Perpetual Sends Letter to Board of Directors of Pacira Biosciences to Immediately Accelerate and Increase its Share Buyback Program to Enhance Return to Shareholders
Prnewswire· 2024-09-25 12:15
Believes Pacira's Cash Balance of $400 million, Roughly 59% of its Market Capitalization, is Grossly Inefficient. Emphasizes the Current Stock Price Offers an Extraordinary Opportunity to Create Meaningful Return for Shareholders MIAMI, Sept. 25, 2024 /PRNewswire/ -- DOMA Perpetual Capital Management LLC today sent a letter to the Board of Directors of Pacira Biosciences (NYSE: PCRX) urging the Board to accelerate and increase its stock repurchase. The letter can be downloaded here The full text of the lett ...
Doma (DOMA) - 2024 Q2 - Quarterly Report
2024-08-14 20:09
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission file number 001-39754 Doma Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 84-1956909 ...
Doma (DOMA) - 2024 Q2 - Quarterly Results
2024-08-13 20:17
Exhibit 99.1 Doma Reports Second Quarter 2024 Financial Results SAN FRANCISCO--(Business Wire)--August 13, 2024-- Doma Holdings, Inc. (NYSE: DOMA) ("Doma" or the "Company"), a leading force for disruptive change in the real estate industry, today reported financial results and key operating data for the three months ended June 30, 2024. Second Quarter 2024 Business Highlights (1)(2): ● Total revenues of $78 million, up 18% versus Q1 2024 ● Retained premiums and fees of $15 million, up 13% versus Q1 2024 ● G ...
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger and Upcoming Vote on August 27, 2024, of Doma Holdings, Inc. - DOMA
GlobeNewswire News Room· 2024-07-27 16:15
NEW YORK, July 27, 2024 (GLOBE NEWSWIRE) -- NEW YORK, July 27, 2024 / GlobeNewswire/-- THE TIME TO ACT IS NOW. The Shareholder Vote is scheduled for August 27, 2024. Click here for more information: https://monteverdelaw.com/case/doma-holdings-inc/. It is free and there is no cost or obligation to you. 1. Do you file class actions and go to Court? 2. When was the last time you recovered money for shareholders? 3. What cases did you recover money in and how much? Our firm litigates and has recovered money fo ...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer
Prnewswire· 2024-07-25 12:15
Believes InMode's Cash Balance of Roughly 55% of its Market Cap is Grossly Inefficient MIAMI, July 25, 2024 /PRNewswire/ -- DOMA Perpetual Capital Management LLC today sent a letter to the Board of Directors of InMode (NYSE: INMD) urging the Board to execute a 40% tender offer of the stock. The full text of the letter follows: To the Board Members of InMode: Over the last few months, we have communicated privately with the Board of Directors of the Company (the "Board") about our concerns regarding the Comp ...
INVESTIGATION: The M&A Class Action Firm Investigates Merger and Imminent Vote on August 27, 2024, of Doma Holdings, Inc. - DOMA
GlobeNewswire News Room· 2024-07-23 16:06
NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and is investigating Doma Holdings, Inc. (NYSE: DOMA), relating to its proposed sale to Title Resources Group. Under the terms of the agreement, DOMA shareholders are expected to receive $6.29 in cash per shar ...